CDD (Collaborative Drug Discovery)
Company overview:
CDD’s mission is to provide an unparalleled software experience for humanitarian and commercial collaborative research and discovery, and it aims to achieve this by focusing on its people, values, goals, innovation, and technology. CDD was established in 2004 when founder and CEO Barry Bunin was an entrepreneur in residence at Eli Lilly & Co. Its flagship product, CDD Vault, was designed to address the problem of inefficient data management in the field of biological and chemical research. Over the years, it has been able to significantly expand the capabilities of its platform, as well as its user base, and is now helping hundreds of organisations and thousands of scientists globally collaborate more effectively every day. It is a hosted, out-of-the-box solution that aims to streamline software to simplify data complexities for users. It provides a RESTful API with clear documentation to enable users to integrate with other applications in their workflows, with exemplary support systems.
